Devices & Diagnostics
-
FDA Clearance Spotlight: Ceribell
Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.
-
Emergency Dialysis: A Crutch for Fee-For-Service Healthcare
Physicians often diagnose patients with chronic kidney disease (CKD) too late in the process, when dialysis is the only option left. This isn’t negligence on the part of physicians — it’s simply a consequence of a fee-for-service (FFS) healthcare model that works against patients’ financial well-being and deemphasizes preventative care.
-
The Challenges of Temperature Controlled Logistics and How to Overcome Them
MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
-
Devices & Diagnostics, Artificial Intelligence
FDA Clearance Spotlight: UltraSight
UltraSight, based in Israel, recently received a nod from the FDA to market its UltraSight AI Guidance product that can assist medical professionals without sonography experience in acquiring cardiac ultrasound images and allow for more widespread detection of heart diseases.
-
Devices & Diagnostics, Artificial Intelligence, BioPharma
Newly Public Allurion Aims to Show How Med Tech Can Complement Obesity Drugs
Allurion Technologies has commercialized a gastric balloon in the form of a pill that patients swallow. But the weight loss platform from the now NYSE-listed company also includes AI-driven software that provides insights about a patient’s progress, technology with the potential for use alongside obesity drugs.
-
BioPharma, Consumer / Employer, Devices & Diagnostics, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
MedCity Influencers, BioPharma
Clinical Trials Have A Data Problem. Here’s How The Industry Can Solve It.
To maximize the digital clinical trial opportunity, it is imperative to establish a solid foundation of data collection and management best practices and capitalize on the advancements in data management technologies.
-
MedCity Influencers, Devices & Diagnostics
Medical Devices Are Evolving Toward Specialized Solutions
Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations […]
-
MedCity Influencers, Devices & Diagnostics
To Optimize Health Outcomes, Home Medical Devices Must Operate Within Disease Management Programs
Rich multimedia content, chatbots and human interaction all play important roles in helping new health technologies become part of a patient’s lifestyle.
-
Creating an Omnichannel Customer Journey in Healthcare
Improving Customer Experience and Conversion in Healthcare & Life Sciences
-
Startup Fundraising Spotlight: Octave Bioscience
Octave Bioscience, based in Menlo Park, California, just closed a $30 million extension to its Series B funding round.
-
Devices & Diagnostics, BioPharma
Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics
Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.
-
Devices & Diagnostics, Health Tech
VR Can Alleviate Brain Tumor Patients’ Anxiety During Treatment, Study Finds
AppliedVR teamed up with the National Cancer Institute to study the feasibility of VR to alleviate anxiety in brain tumor patients undergoing imaging scans. The research partners recently announced interim analysis results from their clinical study — they said that not only would VR intervention be a feasible option to reduce patients’ anxiety, but that patients would report high satisfaction levels as well.
-
How a ‘Costco Model’ for Health Care Supply Chain Presents a Best Bet for Value
By reimagining health care supply chain as a centralized, high-value distribution and product selection and procurement model, hospitals and health systems can more effectively reach their goals for expense reduction while driving substantial improvements for patients and team members alike.
-
MedCity Influencers, Devices & Diagnostics
Right Now: ‘Insourcing’ Dialysis Can Deliver Big Cost Savings, Better Outcomes
When facilities operate their own acute dialysis operations and no longer enlist third parties to provide treatment, they save hundreds of dollars per session. Insourcing also enables hospitals to keep trained dialysis staff on hand full-time to actively ensure quality kidney care to their patients.